Mismatch repair deficiency may affect clinical outcome through immune response activation in metastatic gastric cancer patients receiving first-line chemotherapy

被引：0
|
作者：
Riccardo Giampieri
Elena Maccaroni
Alessandra Mandolesi
Michela Del Prete
Kalliopi Andrikou
Luca Faloppi
Alessandro Bittoni
Maristella Bianconi
Marina Scarpelli
Raffaella Bracci
Mario Scartozzi
Stefano Cascinu
机构：
[1] Azienda Ospedaliero Universitaria Ospedali Riuniti,Department of Medical Oncology
[2] Università Politecnica delle Marche,Department of Pathology
[3] Università Politecnica delle Marche,Department of Medical Oncology
[4] Università di Cagliari,undefined
来源：
Gastric Cancer | 2017年 / 20卷
关键词：
Gastric cancer; Mismatch repair; Microsatellite instability; Chemotherapy; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：156 / 163
页数：7
相关论文
共 50 条
  • [31] Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment
    Kjersem, J. B.
    Ikdahl, T.
    Lingjaerde, O. C.
    Guren, T.
    Tveit, K. M.
    Kure, E. H.
    MOLECULAR ONCOLOGY, 2014, 8 (01) : 59 - 67
  • [32] Venous thromboembolism risk in cancer patients receiving first-line immune checkpoint inhibitor versus chemotherapy
    Li, Ang
    May, Sarah B.
    La, Jennifer
    Martens, Kylee L.
    Amos, Christopher I.
    Flowers, Christopher R.
    Do, Nhan V.
    Brophy, Mary T.
    Chitalia, Vipul
    Ravid, Katya
    Gaziano, John Michael
    Fillmore, Nathanael R.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (08) : 1214 - 1222
  • [33] Exposure to Antibiotics May Affect Progression-Free Survival Negatively in NSCLC Patients Receiving First-Line Chemotherapy
    Tian, X.
    Gong, Y.
    Mei, T.
    Yang, X.
    Xu, Y.
    Yu, M.
    Li, Y.
    Zhu, J.
    Huang, M.
    Zhang, Y.
    Peng, F.
    Zhou, L.
    Zhou, X.
    Xue, J.
    Liu, Y.
    Zou, B.
    Wang, Y.
    Lu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S397 - S398
  • [34] Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
    L Paré
    E Marcuello
    A Altés
    E del Río
    L Sedano
    J Salazar
    A Cortés
    A Barnadas
    M Baiget
    British Journal of Cancer, 2008, 99 : 1050 - 1055
  • [35] Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy
    Pare, L.
    Marcuello, E.
    Altes, A.
    del Rio, E.
    Sedano, L.
    Salazar, J.
    Cortes, A.
    Barnadas, A.
    Baiget, M.
    BRITISH JOURNAL OF CANCER, 2008, 99 (07) : 1050 - 1055
  • [36] Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
    An, Minae
    Mehta, Arnav
    Min, Byung Hoon
    Heo, You Jeong
    Wright, Samuel J.
    Parikh, Milan
    Bi, Lynn
    Lee, Hyuk
    Kim, Tae Jun
    Lee, Song-Yi
    Moon, Jeonghyeon
    Park, Ryan J.
    Strickland, Matthew R.
    Park, Woong-Yang
    Kang, Won Ki
    Kim, Kyoung-Mee
    Kim, Seung Tae
    Klempner, Samuel J.
    Lee, Jeeyun
    CANCER DISCOVERY, 2024, 14 (05) : 766 - 785
  • [37] The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer
    Kim, Seung Tae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    Kim, Jin Yong
    Kim, Young Ho
    Chang, Dong Kyung
    Rhee, Poong-Lyul
    Kim, Dae Shick
    Yun, Haeran
    Cho, Yong Beom
    Kim, Hee Cheol
    Yun, Seong Hyeon
    Chun, Ho-Kyung
    Lee, Woo Yong
    Park, Young Suk
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1277 - 1285
  • [38] The effect of DNA mismatch repair (MMR) status on oxaliplatin-based first-line chemotherapy as in recurrent or metastatic colon cancer
    Seung Tae Kim
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Jin Yong Kim
    Young Ho Kim
    Dong Kyung Chang
    Poong-Lyul Rhee
    Dae Shick Kim
    Haeran Yun
    Yong Beom Cho
    Hee Cheol Kim
    Seong Hyeon Yun
    Ho-Kyung Chun
    Woo Yong Lee
    Young Suk Park
    Medical Oncology, 2010, 27 : 1277 - 1285
  • [39] DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy
    Ronchetti, Livia
    Melucci, Elisa
    De Nicola, Francesca
    Goeman, Frauke
    Casini, Beatrice
    Sperati, Francesca
    Pallocca, Matteo
    Terrenato, Irene
    Pizzuti, Laura
    Vici, Patrizia
    Sergi, Domenico
    Di Lauro, Luigi
    Amoreo, Carla Azzurra
    Gallo, Enzo
    Diodoro, Maria Grazia
    Pescarmona, Edoardo
    Vitale, Ilio
    Barba, Maddalena
    Buglioni, Simonetta
    Mottolese, Marcella
    Fanciulli, Maurizio
    De Maria, Ruggero
    Maugeri-Sacca, Marcello
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (11) : 2587 - 2595
  • [40] KRAS MUTATIONS AND OUTCOME IN PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH FIRST-LINE CHEMOTHERAPY WITH OR WITHOUT CETUXIMAB
    Tejpar, Sabine
    Bokemeyer, Carsten
    Celik, Ilhan
    Schlichting, Michael
    Heeger, Steffen
    Van Cutsem, Eric
    ANNALS OF ONCOLOGY, 2011, 22 : v16 - v17
12345